Rapid value assessment and price prediction
GPI horizon is a unique platform solution, based on our award-winning methodology, that quantifies an asset’s position in the market.
Using the latest technology and robust data sources, GPI horizon delivers rapid value assessment and price prediction to inform: portfolio strategy and prioritisation, investment decisions for early assets, strategic price and access planning for assets leading up to launch, price revisions throughout the product lifecycle. This makes GPI horizon perfect for not only price forecasting, but for quick and valuable insights throughout your asset's lifecycle.
Schedule a free demo
Why you need value assessment and price prediction
Increased Speed of drug launches
Rapidly quantify value across competitors and pipeline products.
In 2018, the number of new medicines approved by the FDA doubled, from 31 in 2008 to 62. While currently, more than 8,000 compounds are in development.
Increased risk, pressure & complexity of launching new drugs
The average peak sales per pipeline asset have not increased from $520M in 2013, to $521M in 2021. Plus, only 1 out of every 10 assets makes it from phase 1 to regulatory approval.
Higher costs involved in bringing new drugs to market
The cost of bringing an asset to market doubled from $1.3bn in 2013 to $2.4bn in 2019.
No evidence-based, analytical solution on the market
The future of price and access will require speed, agility and evidence-based insights... earlier
Improve the efficiency of your drug launch, with the GPI horizon methodology platform
Do in days, what used to take months...
Shortened project times and more robust outputs
Evidence-led, robust decision making
Readily available price and access data via GPI pulse™
Faster, more accurate decision making, earlier in the lifecycle
Rapidly quantify value across competitors and pipeline products.
Lower the risk of new drug launches
Analytical and scalable framework for value and price assessment
Flexibility and transparency in decision making
Payer-validated and transparent methodology
Schedule a free demo
GPI horizon provides a continuous, agile journey - underpinned by data
Traditional pricing and access activities are resource intensive and provide a snapshot in time. GPI horizon enables a faster and more agile way of working that is backed by GPI pulse™ data.
Wherever you are in the product lifecycle, and we’ll create the right solution for you:
BD&L / Early Pipeline
Pre-clinical – Early Phase 2
BD&L / Early Pipeline
• Rapid and more comprehensive asset evaluations to inform investment decisions
• Analogue selection supported by data from comprehensive GPI pulse™ database
• Test alternative scenarios and multiple assets quickly
• Transparent and payer-validated methodology
• Reduce internal burden and lengthy contracting
Late Phase
Phase 2-3
Late Phase
• Bespoke strategy and actionable recommendations from experienced P&MA consulting team
• Analogue selection supported by data from comprehensive GPI pulse™ database
• Faster project timelines leveraging analytical framework and readily available data
• Transparent and payer-validated methodology
• Rapid and continuous assessment of scenarios in response to evolving landscape
Leverage GPI horizon throughout the development lifecycle, and most therapy areas
Early Pipeline Use Cases
Rapidly evaluate price and access potential for an early asset
Weigh up several TPP (target product profile) scenarios to inform strategy
Systematically prioritize a selection of assets for an optimized portfolio
Generate evidence to enhance price potential with a clear understanding of payer value perception
Understand the clinical hurdles required to meet a certain price
Quickly re-evaluate price and adjust your strategy due to an evolving landscape
Late Phase
Optimise valuable payer research time with more streamlined discussions
Weigh up several TPP (target product profile) scenarios to inform strategy
Develop an evidence-based approach to negotiate price with payers
Generate evidence to enhance price potential with a clear understanding of payer value perception
Identify the optimal subsequent launch indications to preserve price
Quickly re-evaluate price and adjust your strategy due to an evolving landscape
How GPI horizon can be used
Self-serve platform subscription
Self-serve platform subscription
Evaluations completed by the user – instantly.
Serviced platform subscription
Serviced Platform Subscription
Evaluations completed on-demand by GPI consulting.
Time frame: 3-10 business days per evaluation
Bespoke pricing & market access strategy projects
Bespoke Pricing & Access Strategy Projects
Project delivered by GPI consulting.
Time frame: 8 weeks on average, subject to scope.
Engage with us
Register your interest
in GPI solutions
Sign up for
GPI updates